rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Inspire Medical Systems, Inc.

INSP · NYSE

Health CareMedical DevicesJust started moving

INSP stood above a rising 150-day average in 3 of the last 52 weekly readings, including each of the last 3 weeks. It is 25.4% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
3 in a row
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$910K
Officials’ trades on record
2
Institutions holding
252 (-22)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$4.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 1, Senate 0, executive 1; 2 people.

WhoDidAmountTraded
Bryan Bedford Executive branch: Office of Government EthicsDepartment of Transportationsold$1k–$15k10 Sep 2025filed 19 Dec 2025
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k10 Apr 2023filed 19 May 2023

Insiders

Buy orders, 12 months0
Sale orders, 12 months7
Buyers · sellers0 · 3
WhoDidSharesTraded
Jason P. KellyOfficersold963at $59.557 Aug 2026filed 11 Aug 2026
John RondoniOfficersold2,641at $43.2815 May 2026filed 19 May 2026
John RondoniOfficersold700at $43.0114 May 2026filed 15 May 2026
Shawn McCormickDirectorsold696at $45.318 May 2026filed 11 May 2026
John RondoniOfficersold109at $100.009 Jan 2026filed 12 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders252-22 on the quarter
New · exited68 · 91
Reported value$1.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,737,519$211.3M+1,187,965+33.5%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 20262,382,660$106.3M-153,294−6.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20262,088,961$93.2M+451,788+27.6%
Soleus Capital Management, L.P.added · filed 11 Aug 20261,931,436$86.2M+1,355,137+235.1%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 20261,856,800$80.9M+1,548,138+501.6%
UBS Group AGadded · filed 13 Aug 20261,645,511$73.4M+1,006,583+157.5%
D. E. Shaw & Co., Inc.added · filed 14 Aug 20261,470,462$65.6M+281,925+23.7%
NOMURA HOLDINGS INCnew · filed 14 Aug 20261,369,410$61.1M+1,369,410
DEERFIELD MANAGEMENT COMPANY, L.P.reduced · filed 14 Aug 20261,296,862$57.9M-1,406,376−52.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,270,928$56.7M+4,190+0.3%
31 Mar 2023 – 30 Jun 2026
255294333Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Gary Lee Ellis Company insiderDirector · last 14 Oct 20260 · 0
Georgia Melenikiotou Company insiderDirector · last 14 Oct 20260 · 3
Michael H. Carrel Company insiderDirector · last 14 Oct 20260 · 0
Shelley G. Broader Company insiderDirector · last 14 Oct 20260 · 0
Jason P. Kelly Company insiderOfficer · last 31 Aug 20260 · 1
Melissa Mann Company insiderChief People Officer · last 31 Jul 20260 · 0
Casey M. Tansey Company insiderDirector · last 15 Jul 20261 · 4
John Rondoni Company insiderOfficer · last 15 May 20260 · 16
Shawn mcCormick Company insiderDirector · last 8 May 20261 · 5
Cynthia Burks Company insiderDirector · last 30 Apr 20260 · 0
Dana G. Mead Jr. Company insiderDirector · last 30 Apr 20261 · 0
Myriam Curet Company insiderDirector · last 30 Apr 20262 · 2

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202585.4%
Operating profit marginFY 2025 · to 31 Dec 20255.6%
Free cash flow marginFY 2025 · to 31 Dec 20258.6%
Return on capital employedFY 2025 · to 31 Dec 20256.3%
Cash conversionFY 2025 · to 31 Dec 202580.4%
Research spendFY 2025 · to 31 Dec 202511.3%
Share count trendFY 2025 · to 5 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$104.8M
Free cash flowFY 2025 · to 31 Dec 2025$78.5M

Analyst forecasts

No analyst forecasts yet.